Efficacy of recombinant gamma interferon for treatment of systemic cryptococcosis in SCID mice.
about
Cryptococcus neoformans: Tripping on Acid in the PhagolysosomeCryptococcal interactions with the host immune system.Cytokine signaling regulates the outcome of intracellular macrophage parasitism by Cryptococcus neoformans.Cryptococcal infection and Th1-Th2 cytokine balance.Cytokine profiles at admission can be related to outcome in AIDS patients with cryptococcal meningitisThe relative susceptibility of mouse strains to pulmonary Cryptococcus neoformans infection is associated with pleiotropic differences in the immune response.Efficacy of gamma interferon and specific antibody for treatment of microsporidiosis caused by Encephalitozoon cuniculi in SCID mice.Animal models: an important tool in mycology.Cytokine and inducible nitric oxide synthase mRNA expression during experimental murine cryptococcal meningoencephalitis.Pharmacotherapy of cryptococcosis.Immune modulators as adjuncts for the prevention and treatment of invasive fungal infections.Cryptococcosis: epidemiology, fungal resistance, and new alternatives for treatment.Intraspecies variation in the efficacy of adjunctive recombinant interferon-γ therapy against cryptococcal meningoencephalitis in mice.Efficacy of liposomal amphotericin B combined with gamma interferon or granulocyte-macrophage colony-stimulating factor for treatment of systemic zygomycosis in mice.Experimental systemic infection with Cryptococcus neoformans var. grubii and Cryptococcus gattii in normal and immunodeficient mice.Quantitative Simulations Predict Treatment Strategies Against Fungal Infections in Virtual Neutropenic Patients.
P2860
Q26765874-DD6A5A6E-B0AE-4AD0-8931-BCFD9D2AD4D0Q30387948-8F7EB916-ABE1-426D-B990-62FD299847B3Q34984326-B5560109-9BE0-4AE4-BDE9-509EB96BCCE6Q35027538-18ED7903-1EFD-4154-B0CF-EAFF695EBDDCQ35208706-0171E7F1-7934-42B1-B244-C997CE3F09C8Q35913526-DBF2E11D-4F63-4F4A-B2EE-42808A555134Q36702992-EF4879CB-2159-4C6F-9F3A-395C4A4C6335Q37008692-80FE62F8-484C-42DA-856F-715B38E60071Q37115803-1D73F891-A682-4E74-BF2F-9B959C65A2B5Q37587230-E647CE49-4C6E-49A4-822E-8734A920A800Q38067451-65B6C918-6479-4652-B8F5-AB822C6EBD4DQ38154164-06E70A9E-7947-438B-993D-2A1F4CAA72ABQ41989526-CCE27AB4-77B2-48E0-9BA9-86AFFFEC81C9Q42095363-FE0593AE-8FFC-4593-BBBB-328743B6D9E0Q46689726-D919A873-17D0-4A55-A7C0-C76AB92E2832Q52579138-71D973B0-A97D-4CF3-A81D-EACDCCBE72F9
P2860
Efficacy of recombinant gamma interferon for treatment of systemic cryptococcosis in SCID mice.
description
2001 nî lūn-bûn
@nan
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
2001年论文
@zh
2001年论文
@zh-cn
name
Efficacy of recombinant gamma ...... c cryptococcosis in SCID mice.
@en
Efficacy of recombinant gamma ...... c cryptococcosis in SCID mice.
@nl
type
label
Efficacy of recombinant gamma ...... c cryptococcosis in SCID mice.
@en
Efficacy of recombinant gamma ...... c cryptococcosis in SCID mice.
@nl
prefLabel
Efficacy of recombinant gamma ...... c cryptococcosis in SCID mice.
@en
Efficacy of recombinant gamma ...... c cryptococcosis in SCID mice.
@nl
P2093
P2860
P1476
Efficacy of recombinant gamma ...... c cryptococcosis in SCID mice.
@en
P2093
P2860
P304
P356
10.1128/AAC.45.3.686-689.2001
P407
P577
2001-03-01T00:00:00Z